{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,9]],"date-time":"2026-06-09T14:31:43Z","timestamp":1781015503574,"version":"3.54.1"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,5,24]],"date-time":"2020-05-24T00:00:00Z","timestamp":1590278400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,5,24]],"date-time":"2020-05-24T00:00:00Z","timestamp":1590278400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Clinical Research Fund from Zhongshan Hospital of Fudan University","award":["2016ZSLC05"],"award-info":[{"award-number":["2016ZSLC05"]}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81772720"],"award-info":[{"award-number":["81772720"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Research Funding from Jiangsu Commission of Health","award":["BM2018023-3"],"award-info":[{"award-number":["BM2018023-3"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Epigenet"],"published-print":{"date-parts":[[2020,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n<jats:title>Background<\/jats:title>\n<jats:p>Epigenetic alterations are involved in most cancers, but its application in cancer diagnosis is still limited. More practical and intuitive methods to detect the aberrant expressions from clinical samples using highly sensitive biomarkers are needed. In this study, we developed a novel approach in identifying, visualizing, and quantifying the biallelic and multiallelic expressions of an imprinted gene panel associated with cancer status. We evaluated the normal and aberrant expressions measured using the imprinted gene panel to formulate diagnostic models which could accurately distinguish the imprinting differences of normal and benign cases from cancerous tissues for each of the ten cancer types.<\/jats:p>\n<\/jats:sec><jats:sec>\n<jats:title>Results<\/jats:title>\n<jats:p>The Quantitative Chromogenic Imprinted Gene In Situ Hybridization (QCIGISH) method developed from a 1013-case study which provides a visual and quantitative analysis of non-coding RNA allelic expressions identified the guanine nucleotide-binding protein, alpha-stimulating complex locus (<jats:italic>GNAS<\/jats:italic>), growth factor receptor-bound protein (<jats:italic>GRB10<\/jats:italic>), and small nuclear ribonucleoprotein polypeptide N (<jats:italic>SNRPN<\/jats:italic>) out of five tested imprinted genes as efficient epigenetic biomarkers for the early-stage detection of ten cancer types. A binary algorithm developed for cancer diagnosis showed that elevated biallelic expression (BAE), multiallelic expression (MAE), and total expression (TE) measurements for the imprinted gene panel were associated with cell carcinogenesis, with the formulated diagnostic models achieving consistently high sensitivities (91\u201398%) and specificities (86\u201398%) across the different cancer types.<\/jats:p>\n<\/jats:sec><jats:sec>\n<jats:title>Conclusions<\/jats:title>\n<jats:p>The QCIGISH method provides an innovative way to visually assess and quantitatively analyze individual cells for cancer potential extending from hyperplasia and dysplasia until carcinoma in situ and invasion, which effectively supplements standard clinical cytologic and histopathologic diagnosis for early cancer detection. In addition, the diagnostic models developed from the BAE, MAE, and TE measurements of the imprinted gene panel <jats:italic>GNAS<\/jats:italic>, <jats:italic>GRB10<\/jats:italic>, and <jats:italic>SNRPN<\/jats:italic> could provide important predictive information which are useful in early-stage cancer detection and personalized cancer management.<\/jats:p>\n<\/jats:sec>","DOI":"10.1186\/s13148-020-00861-1","type":"journal-article","created":{"date-parts":[[2020,5,24]],"date-time":"2020-05-24T11:02:52Z","timestamp":1590318172000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":19,"title":["Novel visualized quantitative epigenetic imprinted gene biomarkers diagnose the malignancy of ten cancer types"],"prefix":"10.1186","volume":"12","author":[{"given":"Rulong","family":"Shen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tong","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chuanliang","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rex C.","family":"Yung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiandong","family":"Bao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xing","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongyu","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shaohua","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huixiong","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongxun","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jian","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenbo","family":"Bu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaonan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Han","family":"Si","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Panying","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pengcheng","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yun","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yongjie","family":"Deng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yun","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuxiong","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John P.","family":"Pineda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chunlin","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ning","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0119-8990","authenticated-orcid":false,"given":"Chunxue","family":"Bai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,5,24]]},"reference":[{"issue":"2","key":"861_CR1","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1038\/s41576-018-0071-5","volume":"20","author":"E Heitzer","year":"2019","unstructured":"Heitzer E, Haque IS, Roberts CES, Speicher MR. Current and future perspectives of liquid biopsies in genomics-driven oncology. Nat Rev Genet. 2019;20(2):71\u201388.","journal-title":"Nat Rev Genet"},{"issue":"1","key":"861_CR2","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1038\/s41467-018-03033-1","volume":"9","author":"R Liu","year":"2018","unstructured":"Liu R, Zhang T, Zhu G, Xing M. Regulation of mutant TERT by BRAF V600E\/MAP kinase pathway through FOS\/GABP in human cancer. Nat Commun. 2018;9(1):579.","journal-title":"Nat Commun"},{"issue":"3","key":"861_CR3","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1038\/s41591-018-0323-0","volume":"25","author":"VH Teixeira","year":"2019","unstructured":"Teixeira VH, Pipinikas CP, Pennycuick A, Lee-Six H, Chandrasekharan D, Beane J, Morris TJ, Karpathakis A, Feber A, Breeze CE, et al. Deciphering the genomic, epigenomic, and transcriptomic landscapes of pre-invasive lung cancer lesions. Nat Med. 2019;25(3):517\u201325.","journal-title":"Nat Med"},{"key":"861_CR4","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1146\/annurev-biochem-060815-014710","volume":"85","author":"AC Joerger","year":"2016","unstructured":"Joerger AC, Fersht AR. The p53 pathway: origins, inactivation in cancer, and emerging therapeutic approaches. Annu Rev Biochem. 2016;85:375\u2013404.","journal-title":"Annu Rev Biochem"},{"issue":"5","key":"861_CR5","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1093\/jnci\/dji055","volume":"97","author":"H Shigematsu","year":"2005","unstructured":"Shigematsu H, Lin L, Takahashi T, Nomura M, Suzuki M, Wistuba II, Fong KM, Lee H, Toyooka S, Shimizu N, et al. Clinical and biological features associated with epidermal growth factor receptor gene mutations in lung cancers. J Natl Cancer Inst. 2005;97(5):339\u201346.","journal-title":"J Natl Cancer Inst"},{"issue":"8","key":"861_CR6","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0182562","volume":"12","author":"R Zhuang","year":"2017","unstructured":"Zhuang R, Li S, Li Q, Guo X, Shen F, Sun H, Liu T. The prognostic value of KRAS mutation by cell-free DNA in cancer patients: a systematic review and meta-analysis. PLoS One. 2017;12(8):e0182562.","journal-title":"PLoS One"},{"issue":"4","key":"861_CR7","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1016\/j.ejca.2004.10.029","volume":"41","author":"HF Vasen","year":"2005","unstructured":"Vasen HF, Tesfay E, Boonstra H, Mourits MJ, Rutgers E, Verheyen R, Oosterwijk J, Beex L. Early detection of breast and ovarian cancer in families with BRCA mutations. Eur J Cancer. 2005;41(4):549\u201354.","journal-title":"Eur J Cancer"},{"issue":"2","key":"861_CR8","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1007\/s10147-018-1375-3","volume":"24","author":"T Wakai","year":"2018","unstructured":"Wakai T, Prasoon P, Hirose Y, Shimada Y, Ichikawa H, Nagahashi M. Next-generation sequencing-based clinical sequencing: toward precision medicine in solid tumors. Int J Clin Oncol. 2018;24(2):115\u201322.","journal-title":"Int J Clin Oncol"},{"issue":"14","key":"861_CR9","doi-asserted-by":"publisher","first-page":"1323","DOI":"10.1056\/NEJMra1402513","volume":"378","author":"AP Feinberg","year":"2018","unstructured":"Feinberg AP. The key role of epigenetics in human disease prevention and mitigation. N Engl J Med. 2018;378(14):1323\u201334.","journal-title":"N Engl J Med"},{"key":"861_CR10","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1101\/cshperspect.a018382","volume":"6","author":"DP Barlow","year":"2014","unstructured":"Barlow DP, Bartolomei MS. Genomic imprinting in mammals. Cold Spring Harb Perspect Biol. 2014;6:2.","journal-title":"Cold Spring Harb Perspect Biol"},{"issue":"3","key":"861_CR11","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1002\/path.2116","volume":"211","author":"P Jelinic","year":"2007","unstructured":"Jelinic P, Shaw P. Loss of imprinting and cancer. J Pathol. 2007;211(3):261\u20138.","journal-title":"J Pathol"},{"issue":"5","key":"861_CR12","doi-asserted-by":"publisher","first-page":"704","DOI":"10.4161\/epi.28006","volume":"9","author":"T Ribarska","year":"2014","unstructured":"Ribarska T, Goering W, Droop J, Bastian KM, Ingenwerth M, Schulz WA. Deregulation of an imprinted gene network in prostate cancer. Epigenetics. 2014;9(5):704\u201317.","journal-title":"Epigenetics"},{"key":"861_CR13","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1186\/s12967-015-0467-3","volume":"13","author":"IJ Matouk","year":"2015","unstructured":"Matouk IJ, Halle D, Gilon M, Hochberg A. The non-coding RNAs of the H19-IGF2 imprinted loci: a focus on biological roles and therapeutic potential in Lung Cancer. J Transl Med. 2015;13:113.","journal-title":"J Transl Med"},{"issue":"17","key":"861_CR14","doi-asserted-by":"publisher","first-page":"2633","DOI":"10.1093\/hmg\/ddn163","volume":"17","author":"Y Ito","year":"2008","unstructured":"Ito Y, Koessler T, Ibrahim AE, Rai S, Vowler SL, Abu-Amero S, Silva AL, Maia AT, Huddleston JE, Uribe-Lewis S, et al. Somatically acquired hypomethylation of IGF2 in breast and colorectal cancer. Hum Mol Genet. 2008;17(17):2633\u201343.","journal-title":"Hum Mol Genet"},{"key":"861_CR15","doi-asserted-by":"publisher","first-page":"1888","DOI":"10.1100\/tsw.2006.318","volume":"6","author":"A Murrell","year":"2006","unstructured":"Murrell A. Genomic imprinting and cancer: from primordial germ cells to somatic cells. ScientificWorldJournal. 2006;6:1888\u2013910.","journal-title":"ScientificWorldJournal"},{"issue":"3","key":"861_CR16","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1002\/ijc.29419","volume":"137","author":"TM Barrow","year":"2015","unstructured":"Barrow TM, Barault L, Ellsworth RE, Harris HR, Binder AM, Valente AL, Shriver CD, Michels KB. Aberrant methylation of imprinted genes is associated with negative hormone receptor status in invasive breast cancer. Int J Cancer. 2015;137(3):537\u201347.","journal-title":"Int J Cancer"},{"issue":"3","key":"861_CR17","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1007\/s11060-010-0275-9","volume":"101","author":"SH Lee","year":"2011","unstructured":"Lee SH, Appleby V, Jeyapalan JN, Palmer RD, Nicholson JC, Sottile V, Gao E, Coleman N, Scotting PJ. Variable methylation of the imprinted gene, SNRPN, supports a relationship between intracranial germ cell tumours and neural stem cells. J Neuro-Oncol. 2011;101(3):419\u201328.","journal-title":"J Neuro-Oncol"},{"key":"861_CR18","first-page":"181","volume":"2019","author":"L Feng","year":"1894","unstructured":"Feng L, Lou J. DNA methylation analysis. Methods Mol Biol. 1894;2019:181\u2013227.","journal-title":"Methods Mol Biol"},{"issue":"1","key":"861_CR19","doi-asserted-by":"publisher","first-page":"4120","DOI":"10.1038\/s41467-018-06566-7","volume":"9","author":"T Goovaerts","year":"2018","unstructured":"Goovaerts T, Steyaert S, Vandenbussche CA, Galle J, Thas O, Van Criekinge W, De Meyer T. A comprehensive overview of genomic imprinting in breast and its deregulation in cancer. Nat Commun. 2018;9(1):4120.","journal-title":"Nat Commun"},{"key":"861_CR20","first-page":"169","volume":"181","author":"G Braidotti","year":"2001","unstructured":"Braidotti G. RNA-FISH to analyze allele-specific expression. Methods Mol Biol. 2001;181:169\u201380.","journal-title":"Methods Mol Biol"},{"issue":"1","key":"861_CR21","doi-asserted-by":"publisher","first-page":"73","DOI":"10.2217\/epi.13.72","volume":"6","author":"B Huang","year":"2014","unstructured":"Huang B, Jiang C, Zhang R. Epigenetics: the language of the cell? Epigenomics. 2014;6(1):73\u201388.","journal-title":"Epigenomics"},{"issue":"1","key":"861_CR22","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1016\/j.bbagrm.2015.06.015","volume":"1859","author":"J Liz","year":"2016","unstructured":"Liz J, Esteller M. lncRNAs and microRNAs with a role in cancer development. Biochim Biophys Acta. 2016;1859(1):169\u201376.","journal-title":"Biochim Biophys Acta"},{"issue":"12","key":"861_CR23","doi-asserted-by":"publisher","first-page":"743","DOI":"10.1038\/nrm.2016.104","volume":"17","author":"AD Schmitt","year":"2016","unstructured":"Schmitt AD, Hu M, Ren B. Genome-wide mapping and analysis of chromosome architecture. Nat Rev Mol Cell Biol. 2016;17(12):743\u201355.","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"1","key":"861_CR24","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1186\/s12885-017-3693-7","volume":"17","author":"IA Cree","year":"2017","unstructured":"Cree IA, Uttley L, Buckley Woods H, Kikuchi H, Reiman A, Harnan S, Whiteman BL, Philips ST, Messenger M, Cox A, et al. The evidence base for circulating tumour DNA blood-based biomarkers for the early detection of cancer: a systematic mapping review. BMC Cancer. 2017;17(1):697.","journal-title":"BMC Cancer"},{"key":"861_CR25","doi-asserted-by":"crossref","unstructured":"Mensah M, Borzi C, Verri C, Suatoni P, Conte D, Pastorino U, Orazio F, Sozzi G, Boeri M. MicroRNA based liquid biopsy: the experience of the plasma miRNA signature classifier (MSC) for lung cancer screening. Journal of visualized experiments : JoVE. 2017;128.","DOI":"10.3791\/56326"},{"issue":"6","key":"861_CR26","doi-asserted-by":"publisher","first-page":"885","DOI":"10.1042\/BCJ20161047","volume":"474","author":"SP Narayanan","year":"2017","unstructured":"Narayanan SP, Singh S, Shukla S. A saga of cancer epigenetics: linking epigenetics to alternative splicing. The Biochemical journal. 2017;474(6):885\u201396.","journal-title":"The Biochemical journal"},{"issue":"1","key":"861_CR27","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1038\/s41467-017-00639-9","volume":"8","author":"A Martin-Trujillo","year":"2017","unstructured":"Martin-Trujillo A, Vidal E, Monteagudo-Sanchez A, Sanchez-Delgado M, Moran S, Hernandez Mora JR, Heyn H, Guitart M, Esteller M, Monk D. Copy number rather than epigenetic alterations are the major dictator of imprinted methylation in tumors. Nat Commun. 2017;8(1):467.","journal-title":"Nat Commun"},{"issue":"1","key":"861_CR28","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1016\/j.jmoldx.2011.08.002","volume":"14","author":"F Wang","year":"2012","unstructured":"Wang F, Flanagan J, Su N, Wang LC, Bui S, Nielson A, Wu X, Vo HT, Ma XJ, Luo Y. RNAscope: a novel in situ RNA analysis platform for formalin-fixed, paraffin-embedded tissues. The Journal of molecular diagnostics : JMD. 2012;14(1):22\u20139.","journal-title":"The Journal of molecular diagnostics : JMD"},{"key":"861_CR29","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1007\/978-1-4939-6716-2_12","volume":"1543","author":"M Soler","year":"2017","unstructured":"Soler M, Boque-Sastre R, Guil S. RNA-FISH to study regulatory RNA at the site of transcription. Methods Mol Biol. 2017;1543:221\u20139.","journal-title":"Methods Mol Biol"},{"issue":"22","key":"861_CR30","doi-asserted-by":"publisher","first-page":"3209","DOI":"10.1093\/bioinformatics\/btr490","volume":"27","author":"EA Howe","year":"2011","unstructured":"Howe EA, Sinha R, Schlauch D, Quackenbush J. RNA-Seq analysis in MeV. Bioinformatics. 2011;27(22):3209\u201310.","journal-title":"Bioinformatics"},{"key":"861_CR31","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1007\/978-3-319-93791-5_3","volume":"1082","author":"BKC Chan","year":"2018","unstructured":"Chan BKC. Applied statistics for human genetics using R. Adv Exp Med Biol. 2018;1082:123\u201344.","journal-title":"Adv Exp Med Biol"}],"container-title":["Clinical Epigenetics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13148-020-00861-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13148-020-00861-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13148-020-00861-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,23]],"date-time":"2021-05-23T23:07:24Z","timestamp":1621811244000},"score":1,"resource":{"primary":{"URL":"https:\/\/clinicalepigeneticsjournal.biomedcentral.com\/articles\/10.1186\/s13148-020-00861-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,5,24]]},"references-count":31,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["861"],"URL":"https:\/\/doi.org\/10.1186\/s13148-020-00861-1","relation":{},"ISSN":["1868-7075","1868-7083"],"issn-type":[{"value":"1868-7075","type":"print"},{"value":"1868-7083","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,5,24]]},"assertion":[{"value":"31 January 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 May 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 May 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The study was approved by the Shanghai Changhai Hospital Ethics Committee, Shanghai Changzheng Hospital Ethics Committee, Zhongshan Hospital Fudan University Ethics Committee, Institute of Dermatology, Chinese Academy of Medical Sciences Ethics Committee, Jiangsu Institute of Nuclear Medicine Ethics Committee, and Shanghai Tenth People\u2019s Hospital Ethics Committee.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"RS, CX, RCY, HY and CB provided consultancies to Lisen Imprinting diagnostics, Inc. TC, and NZ are employees of Lisen Imprinting diagnostics, Inc. No other conflicts were reported.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"71"}}